Impact of diabetes mellitus on urinary continence after holmium laser enucleation of the prostate due to lower urinary tract symptoms: a retrospective study.
benign prostate hyperplasia
diabetes mellitus
enucleation
holmium laser enucleation of the prostate
stress urinary incontinence
Journal
Central European journal of urology
ISSN: 2080-4806
Titre abrégé: Cent European J Urol
Pays: Poland
ID NLM: 101587101
Informations de publication
Date de publication:
2021
2021
Historique:
received:
13
08
2021
revised:
28
09
2021
accepted:
04
10
2021
entrez:
27
1
2022
pubmed:
28
1
2022
medline:
28
1
2022
Statut:
ppublish
Résumé
Diabetes mellitus (DM) is known as a risk factor of stress urinary incontinence after Holmium laser enucleation of the prostate (HoLEP). We aimed to compare the postoperative continence status of patients with and without DM, after HoLEP surgery. A total of 214 patients who underwent HoLEP between January 2017 and January 2020 were retrospectively assessed. Functional outcomes, perioperative total operation time (TOT)(min), enucleation time (ET)(min), enucleation efficiency (EE)(g/min), enucleated tissue weight (ETW)(g), morcellation efficiency (ME)(g/min), morcellation time (MT)(min), continence status, intraoperative and postoperative complications according to Clavien-Dindo classification were recorded. A total of 96 patients had DM additional to benign prostate hyperplasia (BPH) (Group 1), while 118 patients had only benign prostate hyperplasia without DM (Group 2). When comparing preoperative and postoperative functional outcomes, a statistically significant improvement was observed in both groups from baseline to the 1 HoLEP is safe to perform in patients with DM at low complication and urinary incontinence rates.
Identifiants
pubmed: 35083073
doi: 10.5173/ceju.2021.0204
pii: 0204
pmc: PMC8771128
doi:
Types de publication
Journal Article
Langues
eng
Pagination
535-540Informations de copyright
Copyright by Polish Urological Association.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
World J Urol. 2011 Apr;29(2):205-10
pubmed: 20461386
BJU Int. 2007 Jul;100(1):94-101
pubmed: 17419697
Andrologia. 2020 Sep;52(8):e13744
pubmed: 32643827
Int J Urol. 2009 Nov;16(11):915-7
pubmed: 19796130
World J Urol. 2014 Dec;32(6):1543-9
pubmed: 24500193
J Urol. 2017 Sep;198(3):663-670
pubmed: 28456634
World J Urol. 2021 Jan;39(1):135-141
pubmed: 32193652
World J Mens Health. 2015 Aug;33(2):88-94
pubmed: 26331125
Neurourol Urodyn. 2011 Sep;30(7):1343-9
pubmed: 21538499
Neurourol Urodyn. 2002;21(2):167-78
pubmed: 11857671
J Urol. 2012 Apr;187(4):1336-40
pubmed: 22342512
J Endourol. 2010 Oct;24(10):1655-8
pubmed: 20645871
Turk J Urol. 2020 Jan 17;46(3):219-225
pubmed: 32053095
Curr Urol Rep. 2016 Jun;17(6):45
pubmed: 27053186
Neurourol Urodyn. 2007;26(6):814-9
pubmed: 17455274
Int Neurourol J. 2019 Jun;23(2):91-99
pubmed: 31260608
World J Urol. 2015 Apr;33(4):487-93
pubmed: 25416347
Rev Urol. 2015;17(3):140-9
pubmed: 26543428
World J Urol. 2010 Feb;28(1):53-62
pubmed: 20052586
Int Neurourol J. 2016 Mar;20(1):59-68
pubmed: 27032559
World J Urol. 2021 Jan;39(1):143-148
pubmed: 32219512
Investig Clin Urol. 2019 Sep;60(5):333-342
pubmed: 31501795
J Urol. 2011 Nov;186(5):1977-81
pubmed: 21944135
Urol Int. 2016;97(3):310-319
pubmed: 27592103
BJU Int. 2020 Jul;126(1):3
pubmed: 32613765
J Urol. 2000 Jun;163(6):1725-9
pubmed: 10799169
Int Braz J Urol. 2016 Jul-Aug;42(4):740-6
pubmed: 27564285
Eur Urol. 1998;33(1):69-72
pubmed: 9471043
Urology. 2010 Dec;76(6):1451-5
pubmed: 20579706
J Urol. 2004 May;171(5):1959-64
pubmed: 15076321